RE: 12 month survival data RNS15 Jun 2022 18:25
I hardly think it's hyping a share after today's RNS.
It's a bit of a mystery why we have fallen so much given that the reward must be 5 times plus compared to the risk.
But the market is what it is, the probability of success in pharma is so low and Farn have not provided enough key stats to bring in the big boys on Bex but the data seems to be building up nicely.
We missed the boat with Traumakine and Covid and Markku must take his fair share of blame for that.
Like everyone probably I'm disappointed on the timelines and I think he has played us a bit in that respect.
I could never sell now been here too long